Every Form 4 that CareCloud, Inc. (CCLD) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CCLD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CCLD filings page.
CareCloud, Inc. director Anne Busquet reported the vesting and conversion of 7,500 Restricted Stock Units into an equal number of shares of Common Stock on August 8, 2026. The RSUs and resulting shares were acquired under the company’s Amended and Restated Equity Incentive Plan without payment by the reporting person. Following the transaction, Busquet directly held 308,888 shares of common stock and 37,500 Restricted Stock Units.
CareCloud, Inc. director Bill Korn reported the vesting and conversion of 7,500 Restricted Stock Units into an equal number of shares of common stock on August 8, 2026. The RSUs and resulting shares were issued under the company’s Amended and Restated Equity Incentive Plan without payment by Korn. Following this transaction, Korn directly holds 225,383 shares of common stock and 37,500 Restricted Stock Units.
CareCloud, Inc. director Cameron Munter reported the vesting and conversion of 7,500 Restricted Stock Units into 7,500 shares of common stock on August 8, 2026. The equity was acquired under the company’s Amended and Restated Equity Incentive Plan without payment by the reporting person, leaving 216,500 common shares held directly and 37,500 RSUs outstanding.
CareCloud, Inc. director Lawrence Steven Sharnak reported the vesting and conversion of 7,500 restricted stock units into an equal number of shares of common stock on August 8, 2026. The RSUs and resulting shares were issued under the company’s Amended and Restated Equity Incentive Plan without payment by him. Following these transactions, he held 141,500 shares of common stock directly and 37,500 restricted stock units.
CareCloud, Inc. director Cameron Munter reported equity compensation activity. On July 29, 2026 he received a grant of 25,000 restricted stock units, each representing one share of common stock, vesting in four equal installments through July 29, 2028. On July 31, 2026, 6,250 RSUs vested and converted into 6,250 common shares at no cost to him under CareCloud’s Amended and Restated Equity Incentive Plan, increasing his directly held common stock to 209,000 shares.
CareCloud, Inc. director Bill Korn reported equity compensation activity. On July 29, 2026, he received a grant of 25,000 Restricted Stock Units, vesting in four equal installments on January 29, 2027, July 29, 2027, January 29, 2028 and July 29, 2028. On July 31, 2026, 6,250 RSUs vested and converted into 6,250 shares of common stock under the company’s Amended and Restated Equity Incentive Plan, without payment by him, bringing his directly held common stock to 217,883 shares.
CareCloud, Inc. director Lawrence Steven Sharnak reported equity-award activity. On July 29, 2026 he received a grant of 25,000 Restricted Stock Units, each convertible into one share of common stock, vesting in four equal installments on January 29, 2027, July 29, 2027, January 29, 2028 and July 29, 2028.
On July 31, 2026, 6,250 RSUs vested and converted into 6,250 shares of common stock at a conversion price of 0.0000 per share, issued under the company’s Amended and Restated Equity Incentive Plan without payment by Sharnak. Following these transactions, he directly holds 134,000 shares of CareCloud common stock.
CareCloud, Inc. director Anne Busquet reported equity compensation activity, including a new restricted stock unit grant and the vesting of previously awarded units.
On July 29, 2026 she was granted 25,000 restricted stock units vesting in four equal installments between January 29, 2027 and July 29, 2028. On July 31, 2026 6,250 restricted stock units vested and converted into common stock under the company’s equity incentive plan, bringing her direct holdings to 301,388 shares.
CareCloud, Inc. director and executive chairman Haq Mahmud Ul reported a grant of a common stock warrant to purchase 4,300,000 shares of common stock at an exercise price of $5.00 per share, issued pursuant to a Credit Agreement dated April 13, 2026. The warrant is exercisable beginning July 22, 2026, expires July 21, 2031, and vests in accelerated installments over the next 12 months, subject to its terms. Following this grant, he holds warrants covering 4,300,000 underlying shares.
CareCloud, Inc. Chief Executive Officer Stephen Andrew Snyder reported a disposition of 30,790 shares of the company’s Series B Cumulative Redeemable Perpetual Preferred Stock. The shares were removed from his direct holdings at a price of $25.25 per share, leaving him with zero shares of this preferred series.
According to the disclosure, this transaction was carried out through a mandatory redemption of the Series B Preferred Stock by the issuer and was not an open market sale initiated by Snyder.
CareCloud, Inc. interim CFO and Controller Norman Roth reported a mandatory redemption of 6,500 shares of the company’s Series B Cumulative Redeemable Perpetual Preferred Stock. The shares were disposed of at $25.25 per share in a transaction classified as a disposition to the issuer, not an open market sale, leaving no remaining holdings of this preferred security.
CareCloud, Inc. director Bill Korn reported a disposition of 10,800 shares of the company’s Series B Cumulative Redeemable Perpetual Preferred Stock. The shares were transferred back to the issuer at $25.25 per share through a mandatory redemption, and his reported holdings of this preferred stock are now zero.
The transaction was characterized as a disposition to the issuer rather than an open market sale, indicating the redemption was driven by the security’s terms rather than an individual trading decision.
CareCloud, Inc. Chief Strategy Officer A Hadi Chaudhry reported a mandatory redemption of 7,800 shares of Series B Cumulative Redeemable Perpetual Preferred Stock at $25.25 per share. The shares were disposed of back to the issuer, and the reporting person now holds 0 shares of this security.
CareCloud director Lawrence S. Sharnak reported an equity award vesting and share issuance. On February 8, 2026, 7,500 restricted stock units converted into 7,500 shares of CareCloud common stock at a price of $0. According to the filing, these restricted stock units and the resulting shares were granted under the company’s Amended and Restated Equity Incentive Plan without payment by Sharnak.
Following the transaction, Sharnak directly owned 127,750 shares of common stock and 26,250 restricted stock units. This reflects routine compensation-related activity rather than an open-market purchase or sale.
CareCloud, Inc. director Cameron Munter reported a routine equity compensation vesting. On February 8, 2026, 7,500 restricted stock units converted into 7,500 shares of common stock at a price of $0 per share, under the company’s Amended and Restated Equity Incentive Plan.
After this conversion, Munter directly beneficially owned 202,750 shares of CareCloud common stock and 26,250 restricted stock units. The transaction involved no cash payment by the reporting person and reflects standard compensation-based vesting rather than an open‑market purchase or sale.
CareCloud, Inc. director Anne Busquet reported the vesting and conversion of 7,500 restricted stock units into common stock on February 8, 2026. The RSUs and resulting shares were issued under the company’s Amended and Restated Equity Incentive Plan without any cash payment by her.
After this equity award vesting, she directly holds 295,138 shares of CareCloud common stock and 26,250 derivative securities in the form of restricted stock units.
CareCloud, Inc. director Bill Korn reported the vesting and conversion of 7,500 restricted stock units into common stock on February 8, 2026. The RSUs and resulting shares were issued under the company’s Amended and Restated Equity Incentive Plan without any cash payment by Korn.
After this transaction, Korn beneficially owns 211,633 shares of CareCloud common stock directly and 26,250 restricted stock units, reflecting his ongoing equity-based compensation as a director.
CareCloud, Inc. director Bill Korn reported the vesting of equity awards and related share issuance. On January 31, 2026, 6,250 restricted stock units converted into 6,250 shares of common stock at a price of $0.00 under the company’s Amended and Restated Equity Incentive Plan, without payment by Korn. Following this transaction, he directly owned 204,133 shares of common stock and 33,750 restricted stock units.
CareCloud, Inc. director Anne Busquet reported a routine equity award vesting and conversion. On January 31, 2026, 6,250 restricted stock units vested and converted into 6,250 shares of common stock at a price of $0.00 under the company’s Amended and Restated Equity Incentive Plan, without payment by Busquet.
After this transaction, she directly holds 287,638 shares of common stock and 33,750 restricted stock units, reflecting ongoing participation in CareCloud’s long‑term incentive program rather than an open‑market purchase or sale.
CareCloud director Lawrence Steven Sharnak reported the vesting of equity awards and related share issuance. On January 31, 2026, 6,250 restricted stock units converted into 6,250 shares of CareCloud common stock at a price of $0 per share under the company’s Amended and Restated Equity Incentive Plan.
After this transaction, Sharnak directly owned 120,250 shares of common stock and 33,750 restricted stock units. The award vested without cash payment by the reporting person, reflecting compensation delivered in company equity rather than cash.
CareCloud, Inc. director Cameron Munter reported the vesting and conversion of restricted stock units into common stock. On January 31, 2026, 6,250 restricted stock units converted into 6,250 shares of common stock at a price of $0.00 under CareCloud’s Amended and Restated Equity Incentive Plan, without payment by Munter.
After this transaction, Munter directly owned 195,250 shares of CareCloud common stock and 33,750 restricted stock units. The filing reflects equity-based compensation vesting rather than an open‑market purchase or sale.
CareCloud (CCLD) director reported an open-market sale. On 11/10/2025, the reporting person sold 15,000 shares of common stock at a weighted average price of $3.41, with individual trades ranging from $3.40 to $3.43.
Following the transaction, the filer beneficially owns 51,750 shares, held directly. The filing notes that detailed trade breakdowns are available upon request.